Home / Clinical Guideline Hubs / Chapter 14.7
Section 14 — Neonatal Surgery Verify against local policy v1.0 · July 2026 Baylor Ed. 33 cross-checked Sept 2026

Chapter 14.7 — Neonatal Perioperative & Anesthetic Care

Getting the surgical neonate safely through the operating room · Built on pediatric anesthesia and surgical references

Educational guideline — verify locally. Perioperative plans are shared between neonatology, surgery, and anesthesia. Does not replace attending judgment.
BEDSIDE ACTION BOX — Sending a Neonate to Theatre

1. Overview

The Core Idea

The surgical neonate is not a small adult. Immature thermoregulation, limited cardiac and pulmonary reserve, altered drug handling, and vulnerability to apnea, hypoglycemia, and oxygen toxicity all shape perioperative care. Good outcomes come from careful preoperative optimization, meticulous intraoperative homeostasis, and vigilant postoperative monitoring — shared between neonatology, surgery, and anesthesia.

2. Who This Guideline Applies To

Scope
  • Any neonate undergoing surgery or general anesthesia, including former preterm infants.
  • Cross-references: pain/sedation (5.3); ROP screening (2.3); glucose homeostasis (4.x); the specific surgical conditions in 14.1–14.6.

3. Why Neonatal Physiology Matters

FeaturePerioperative consequence
Immature thermoregulation, high surface areaRapid hypothermia → acidosis, coagulopathy, apnea
Limited glycogen storesHypoglycemia with fasting → give dextrose fluids
Immature respiratory control (esp. preterm)Postoperative apnea after anesthesia
Altered drug metabolism/distributionCareful dosing; prolonged drug effects
Retinal vulnerability (preterm)Titrate oxygen to target saturations

4. Preoperative Optimization

Before Theatre
  • Correct volume status, electrolytes, glucose, anemia, and coagulopathy.
  • Decompress the stomach; confirm the airway and access plan.
  • Ensure blood products are available for anticipated losses.
  • Confirm consent and a shared plan among neonatology, surgery, and anesthesia.

5. Intraoperative Priorities

In Theatre
  • Aggressive thermoregulation (warming devices, warmed fluids, minimized exposure).
  • Maintain glucose with dextrose-containing fluids; monitor.
  • Careful fluid and blood-product management for third-spacing and losses.
  • Oxygen titration to target saturations rather than routine high FiO₂.

6. Postoperative Care

After Theatre
  • Fluid and electrolyte management, anticipating third-space losses.
  • Adequate analgesia and monitoring for respiratory depression.
  • Thermoregulation and glucose monitoring continue.
  • Watch the surgical site and reintroduce feeds as directed by surgery.

6+. Baylor Ed. 33 Perioperative Practice, Stomas and Venous Access

Fluids, fasting and preparation
  • Do not fluid-restrict a neonate with an emergent surgical abdomen. Losses come from evaporation off exposed bowel, third-spacing in obstructed bowel, and emesis or gastric drainage, so give maintenance fluid with electrolytes plus replacement. Rule of thumb: about 15–20 mL/kg of insensible loss for every hour the abdomen is open.
  • Shock in a surgical neonate is hypovolaemic until proven otherwise — correct the deficit, including blood products, before surgery.
  • Obstruction: a large sump tube, preferably a Replogle, hand-aspirated and then on intermittent or low continuous suction. Never cap it with a syringe, which stops decompression.
  • Elective fasting: formula up to 6 h, breast milk up to 4 h, and glucose-containing clear fluids up to 2 h before surgery. No infant should go more than 6 h without intake — start IV fluids if surgery is delayed.
  • Labs and products: type and cross-match and CBC; electrolytes with significant losses; gases in the compromised infant. For major abdominal or thoracic surgery, cross-match 20 mL/kg of red cells. For NICU bedside procedures, products must be at the bedside before starting.
  • Prophylaxis: cefazolin for most procedures; agree choice and duration with surgery.
  • Complications: early (<14 days) — bleeding, wound infection or dehiscence, anastomotic leak (typically postoperative days 4–10), abdominal compartment syndrome. Late — adhesive obstruction, fistula, incisional hernia, stoma problems.
Stomas
  • Proximal small-bowel stomas (e.g., NEC, meconium perforation) produce liquid, corrosive, high-volume output with fluid and electrolyte losses. The distal end may be oversewn, brought out as a loop, or as a mucous fistula, which allows decompression of distal obstruction and refeeding of proximal output (1:1 by syringe pump through a labelled tube changed weekly, once surgery, neonatology and intestinal rehabilitation agree; see chapter 11.2).
  • Construction: a stoma should protrude above the skin for a secure bag. In tiny infants with NEC, limited fixation suffices; early ischaemia is common but usually heals if mucosa at fascial level is viable.
  • Care: keep skin clean and dry; leave the bag 1–3 days, change it for any leak, empty at one-third full; remove old adhesive and clean with soap and water without scrubbing. Dermatitis — treat like diaper rash (zinc or petroleum barrier, skin barriers, stoma powder). Cellulitis → first-generation cephalosporin; candida → nystatin; allergic dermatitis → topical steroid.
  • Other complications: peristomal hernia, prolapse, retraction, and fascial-level stricture (common after NEC; dilation sometimes works, revision often needed).
Venous access
  • Peripheral lines infuse volume faster than central lines (shorter catheter). Sites: hand, forearm, lower leg or foot, scalp. Cutdown or percutaneous central access (saphenous, femoral, external or internal jugular, facial veins; subclavian percutaneously) only after peripheral attempts fail — cutdown carries a much higher infection risk.
  • Midline catheters sit in the proximal limb; avoid a mid-clavicular tip (thrombosis). Useful for about 5–7 days of stable peripheral access (e.g., sedation after tracheostomy), poor access when a central line is contraindicated (septicaemia), or a PICC that would not thread centrally. Suitable for antimicrobials, fluids and peripherally tolerated drugs; no continuous vesicants. More phlebitis, occlusion and leaks than central lines; no proven dwell-time limit.
  • Central access for prolonged or hyperosmolar therapy, PN, or failed peripheral access. PICCs can last weeks to months; use ultrasound where possible and keep the catheter-to-vein ratio below 45%. Non-tunnelled percutaneous CVCs are for emergencies — remove within 5–7 days because of infection risk.
  • Choosing the limb (Table 17-1): likely cardiac surgery or possible ECMO (e.g., CDH) → lower-limb PICC; lower limbs in the surgical field (imperforate anus, sacrococcygeal teratoma) → upper limb; possible future haemodialysis → avoid upper-limb lines to preserve fistula sites; home PN for intestinal failure → tunnelled, cuffed, single-lumen internal-jugular line.
  • Tip position: the SVC at the right atrial junction (T3–T5, about two vertebrae below the carina) or the thoracic IVC just above the diaphragm (T8–T10). Not in the right atrium (T6–T7 — arrhythmia, perforation, tamponade); brachiocephalic (T1–T2) and subclavian (clavicular tip) positions are not central. A lower IVC tip is acceptable as infants grow, but near the renal veins (L1–L2) fluids reach the kidneys undiluted — consider replacing at L2–L3 if central access is still needed. Iliac tips sit at L4–L5; an ideal midline tip lies parallel to the humerus or femur.
  • Complications: early — malposition, pneumothorax, vessel perforation with haemothorax or tamponade, pneumopericardium, infection, arrhythmia (fluoroscopic placement and an immediate film reduce these). Late — breakage, CLABSI, tunnel or site infection, occlusion, migration, phlebitis, bacteraemia from access, venous thrombosis. Tunnelled lines need anaesthesia to dissect out the cuff.
  • Occluded catheter: instil alteplase 1 mg/mL at 110% of the lumen volume, dwell 2 h, aspirate; if still blocked repeat once and try again after 2 h, aspirating and discarding the drug when possible. For suspected PN precipitate, 0.1 N hydrochloric acid 0.25–0.5 mL may clear it.
Umbilical catheters (Baylor Ed. 33)
  • Risks: catheters are removed for complications in 5.5–32% of UACs and 10–50% of UVCs. UVCs can cause IVC or atrial thrombosis, portal vein thrombosis (linked to later portal hypertension), hepatic vein thrombosis, haematoma or infarction, and pericardial effusion or tamponade. Duration and position are the main risk factors — risk rises after 6 days, and ideal UVC position is achieved in only 30–73%. Point-of-care ultrasound improves placement. UACs risk vasospasm, thrombosis, embolism, organ ischaemia and limb injury; high UACs (T6–T9) have fewer vascular complications than low ones.
  • UVC indications: birth weight <1250 g, more than 4 failed IV attempts, hypoglycaemia, high-osmolar infusions (Ca, Mg, glucose >12.5%) or some vasoactives, PGE, resuscitation, exchange transfusion, possible ECMO (low UVC in CDH), and selected severe cardiopulmonary compromise. Double-lumen UVC: <1000 g, PGE, severe compromise, possible ECMO. UAC indications: <1000 g or <26 weeks, frequent gases or BP monitoring, CHD needing specific care, possible ECMO, respiratory distress after resuscitation.
  • Contraindications: active infection (positive cultures or systemic signs), distorted anatomy (relative), omphalocele or gastroschisis, NEC, vascular compromise of the legs or target organs, thrombosis of the target vessel. Sizes: 3.5 Fr below 1500 g; 3.5–5 Fr above; 8 Fr exchange catheter in term infants.
  • UVC tip: IVC–right atrial junction, just above the diaphragm at T9–T10. Baylor uses the modified Shukla formula: depth (cm) = (3 × birth weight in kg + 9) ÷ 2, which reduces over-insertion (correct position still only about 31% vs 28% with graphs). If a liver position must be used briefly, pull back to a low position and avoid hyperosmolar solutions or drugs; replace a low UVC as soon as possible with a repositioned UVC, PICC or IV.
  • UAC tip: the high position, T6–T9 (Cochrane: fewer vasospastic, ischaemic and thrombotic complications). Depth (cm) = 3 × birth weight in kg + 9 (Shukla–Ferrara) — correct in 91% versus 50% with surface-measurement graphs.
  • Duration and removal: UAC under 5 days, UVC under 7 days; document any reason to exceed. Remove for CLABSI, NEC, thrombosis or persistent vasospasm or limb ischaemia not relieved by warming the opposite limb, and as soon as drugs finish or other access exists — not kept just for sampling unless frequent sampling is essential. A second placement attempt should stay within the original procedure (except later exchange transfusion); the "two-catheter" technique is not recommended. Always confirm position radiographically (or by ultrasound) after placement or repositioning.
  • Documentation and upkeep: the procedure is incomplete until the film shows an optimal tip. Record how far a high catheter was withdrawn, the final depth, and any reason to leave a suboptimal line. Nurses record insertion depth every shift, and the team reviews depth and ongoing need on daily rounds; a changed depth or suspected displacement needs a film or ultrasound. Catheters can migrate with movement or abdominal distension, or dislodge with serious bleeding.
  • Variances (longer duration, a short-term low UVC, or a double-lumen UVC above 1250 g) must be individualized, with the risk–benefit reasoning documented — e.g., critical CDH, 23–24-week infants, persistent hypoglycaemia, long-term PGE, frequent sampling, or limited alternative access.
  • Also: never infuse drugs or PN through a UAC; an umbilical catheter does not preclude trophic feeds; keep air out of the set-up, since many neonates still have right-to-left shunts. Landmarks for reading the film: renal arteries usually L1–L2, inferior mesenteric artery about L3, coeliac and superior mesenteric origins about T12–L1; avoid the low-UAC zone around these.
IV infiltration and extravasation (Baylor Ed. 33)
  • Most caustic: hypertonic solutions, pressors, calcium-containing fluids and blood. Secure peripheral lines with transparent dressings and check the site often for redness, blanching, oedema, capillary refill over 3 s, or difficulty flushing.
  • When it happens: stop the infusion and disconnect — do not flush. Leave the cannula in only if aspiration or an antidote is planned; otherwise remove it promptly. Tell the physician if the site stays swollen, red, blanched or dark. Elevate the limb (head of bed for scalp sites). Apply dry cold or warm compresses only as the specific drug's guidance says — never heat, especially moist heat. Consider plastic surgery.
  • Hyaluronidase for hypertonic infiltrations — not for dopamine, dobutamine, epinephrine or norepinephrine. After povidone-iodine (dry for 1 minute), inject five 0.2 mL injections of 15 units/mL subcutaneously or intradermally around the leading edge with a 25–30 G needle, changing the needle each time. Best within 1 hour.

7. Postoperative Apnea

A Key Preterm Risk

Former preterm infants are prone to apnea after general anesthesia. Admit them for apnea/bradycardia monitoring (commonly up to around 60 weeks postmenstrual age, per local policy) rather than treating surgery as day-case. Caffeine may be used per protocol.

8. Pain Management

Treat Pain Proactively

Neonates feel and are harmed by untreated pain, which has physiologic and potential neurodevelopmental consequences. Use validated pain scores and a multimodal plan (regional techniques, opioids, acetaminophen) tailored to the procedure — see 5.3 for detail.

9. Monitoring

What to Track
  • Temperature, glucose, and hemodynamics throughout the perioperative period.
  • Respiration and apnea monitoring, especially in former preterm infants.
  • Fluid balance, urine output, and pain scores.

10. Contraindications & Precautions

Safety Cautions
  • Do not discharge a former preterm infant home the same day after general anesthesia — monitor for apnea.
  • Do not use dextrose-free maintenance fluids in a fasting neonate.
  • Do not allow intraoperative hypothermia — it worsens acidosis and bleeding.
  • Do not use routine high FiO₂ in preterm infants — titrate to targets.

11. Escalation & Follow-Up

Escalate When…
  • Recurrent postoperative apnea, instability, or uncontrolled pain.
  • Signs of surgical complication (bleeding, sepsis, dehiscence).
Follow-Up
  • Condition-specific surgical follow-up; developmental surveillance for prolonged/complex courses.
Parent Counselling Points
  • "Newborns need extra care around surgery — keeping them warm, keeping sugars up, and watching breathing closely afterward, especially if they were born early."

12. Key Pearls

High-Value Clinical Pearls
  • Former preterm infants need postoperative apnea monitoring — not day-case surgery.
  • Fasting neonates need dextrose-containing fluids and glucose monitoring.
  • Temperature is a vital sign in the OR — hypothermia causes acidosis and coagulopathy.
  • Titrate oxygen to targets to protect the preterm retina.
  • Treat pain proactively with a multimodal, score-guided plan.

13. Common Mistakes to Avoid

Pitfalls & Better Practice

The recurring errors in neonatal perioperative care.

MistakeWhy it harmsBetter practice
Day-case surgery for a former preterm.Postoperative apnea.Admit for apnea monitoring.
Dextrose-free fasting fluids.Hypoglycemia.Dextrose-containing maintenance + monitoring.
Neglecting warming.Hypothermia, acidosis, bleeding.Aggressive thermoregulation.
Under-treating pain.Physiologic and developmental harm.Multimodal, score-guided analgesia.

14. Board-Style High-Yield Summary

Key Takeaways
  • Optimize volume, electrolytes, glucose, anemia, and coagulation before surgery; decompress the stomach.
  • Thermoregulation and glucose control are perioperative priorities.
  • Former preterm infants need postoperative apnea monitoring (commonly to ~60 weeks PMA).
  • Titrate oxygen to target saturations (ROP); treat pain proactively.
  • Care is shared among neonatology, surgery, and anesthesia.

15. References

Back to Clinical Guideline Hubs